Page 14 | Certara

Press Release

Certara Simcyp® Simulator Results Replace Ten Human Trials for Chronic Myeloid Leukemia (CML) Therapy asciminib

Novartis used PBPK modeling for therapeutic regulatory success. They used model simulations to replace clinical…

CertaraMarch 3, 2026

Conference

Apotekarsocieteten Clinical Pharmacology Strategies in Drug Development

Danielle PillsburyMarch 2, 2026

Live Events

Phoenix Roadshow 2026 – Cambridge

CertaraMarch 2, 2026

Live Events

Phoenix Roadshow 2026 – Raleigh/Durham

CertaraMarch 2, 2026

Blog

Embracing Model-Informed Drug Discovery: The Path to Better Clinical Outcomes

We cover the evidence of biosimulation improving clinical success rates, making the case for model-informed…

CertaraFebruary 27, 2026

Fact Sheet

Document Quality and Management

Ensure submission readiness with Certara’s Document Quality services. We deliver compliant, inspection-ready regulatory documents that…

CertaraFebruary 27, 2026

Fact Sheet

Safety & Pharmacovigilance Writing

Expertly delivering Safety & Pharmacovigilance Writing services, including Aggregate Safety Reports, Risk Management Plans, and…

CertaraFebruary 27, 2026

Live Events

Phoenix Roadshow 2026 – Radnor (Philadelphia area)

CertaraFebruary 27, 2026

Press Release

Certara to Participate in Upcoming Investor Conferences

RADNOR, PA – February 27, 2026 -- Certara, Inc. (Nasdaq: CERT), a global leader in…

CertaraFebruary 27, 2026

On-Demand Webinar

Formulate Faster: A Purpose-Built Toolkit for Bioequivalence (Phoenix IVIVC Toolkit)

This webinar introduces the Phoenix IVIVC Toolkit, showing how to perform BE analysis and build…

CertaraFebruary 27, 2026

© 2026 Certara. All Rights Reserved. | Legal | Privacy policy